₹58.79
−0.74%NSE close, 16 Nov 2026
−14.41%
Krebs Biochemicals and Industries is a small cap company, listed on NSE under the symbol KREBSBIO. At ₹58.79 a share, the market values the whole company at ₹127 crore.
In FY26, it reported sales of ₹24 crore and a net loss of ₹17 crore, an operating margin of -23.0%. Over the last three years, sales fell 22.7% a year.
Promoters hold 72.74% of the shares. Foreign institutions hold 0.50%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 13.7%, and it is 23.5% below its 52-week high.
₹ crore. Standalone figures: the company files no consolidated results.
The financial results for the period ended September 30, 2026.
A copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 29, 2026
Machine Readable financial results for the quarter ended 30.06.2026.
| Dec 2025 |
|---|
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 13.0 | 12.0 | 12.9 | 12.9 | 11.5 | 6.1 | 5.5 | 4.2 | 7.3 | 6.8 | 7.0 | 5.8 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 15.1 | 15.1 | 15.1 | 15.6 | 16.2 | 11.5 | 7.6 | 7.0 | 7.0 | 7.7 | 6.2 | 7.7 |
| Operating profit | −2.1 | −3.1 | −2.2 | −2.7 | −4.7 | −5.4 | −2.1 | −2.8 | 0.3 | −0.9 | 0.8 | −1.9 |
| Operating margin | -16.1% | -26.0% | -17.1% | -21.1% | -41.2% | -88.7% | -38.1% | -66.9% | 4.1% | -12.8% | 11.9% | -33.3% |
| Other income | 0.0 | 0.2 | 0.0 | 0.1 | 0.3 | 0.3 | 0.0 | 0.0 | 0 | 2.0 | 0.2 | 0.0 |
| Interest | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 | 1.6 | 1.7 | 1.7 | 1.8 | 1.9 | 1.9 | 1.9 |
| Depreciation | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| Profit before tax | −5.0 | −5.9 | −5.2 | −5.8 | −7.7 | −8.3 | −5.3 | −6.1 | −3.1 | −2.3 | −2.5 | −5.4 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | −5.0 | −5.9 | −5.2 | −5.8 | −7.7 | −8.3 | −5.3 | −6.1 | −3.1 | −2.3 | −2.5 | −5.4 |
| EPS (₹) | -2.31 | -2.72 | -2.40 | -2.67 | -3.59 | -3.83 | -2.47 | -2.85 | -1.45 | -1.09 | -1.15 | -2.50 |
₹ crore, financial years to March.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 47.8 | 33.4 | 53.7 | 52.9 | 51.4 | 50.4 | 43.3 | 23.7 |
| Expenses | 57.6 | 52.0 | 71.3 | 93.7 | 67.9 | 59.1 | 58.3 | 29.2 |
| Operating profit | −9.8 | −18.6 | −17.6 | −40.8 | −16.5 | −8.7 | −15.0 | −5.5 |
| Operating margin | -20.5% | -55.8% | -32.7% | -77.0% | -32.1% | -17.3% | -34.7% | -23.0% |
| Other income | 0.3 | 0.4 | 0.6 | 7.9 | 1.3 | 0.5 | 0.7 | 2.0 |
| Interest | 6.2 | 5.9 | 6.3 | 5.4 | 3.0 | 4.7 | 5.9 | 7.1 |
| Depreciation | 4.4 | 4.7 | 5.1 | 6.3 | 6.6 | 6.8 | 6.7 | 6.4 |
| Profit before tax | −20.0 | −28.9 | −28.4 | −44.5 | −24.7 | −19.7 | −26.9 | −16.9 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Net profit | −20.0 | −28.9 | −28.4 | −44.5 | −24.7 | −19.7 | −26.9 | −16.9 |
| EPS (₹) | -12.83 | -16.75 | -14.53 | -20.81 | -11.30 | -9.16 | -12.49 | -7.85 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −17.2 | −7.9 | −1.9 | 3.0 |
| From investing | −22.9 | −5.0 | −3.6 | −1.4 |
| From financing | 39.5 | 12.9 | 5.5 | −1.6 |
| Spent on fixed assets | −27.1 | −5.1 | −4.0 | −1.4 |
| Free cash flow | −44.3 | −13.0 | −5.9 | 1.6 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net margin | -41.9% | -86.4% | -52.8% | -84.1% | -48.0% | -39.1% | -62.2% | -71.3% |
| Operating margin | -20.5% | -55.8% | -32.7% | -77.0% | -32.1% | -17.3% | -34.7% | -23.0% |
| Return on assets | – | – | – | – | -14.1% | -11.1% | -15.9% | -10.4% |
| Interest coverage | -2.20 | -3.90 | -3.50 | -7.30 | -7.30 | -3.20 | -3.60 | -1.40 |
| Debt to assets | – | – | – | – | 1.05 | 1.09 | 1.26 | 1.38 |
| Current ratio | – | – | – | – | 0.33 | 0.28 | 0.10 | 0.09 |
| Quick ratio | – | – | – | – | 0.08 | 0.12 | 0.04 | 0.03 |
| Cash ratio | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset turnover | – | – | – | – | 0.29 | 0.28 | 0.26 | 0.15 |
| Fixed asset turnover | – | – | – | – | 0.35 | 0.34 | 0.30 | 0.17 |
| Inventory turnover | – | – | – | – | – | 0.70 | 0.90 | – |
| Receivables turnover | – | – | – | – | 97.00 | 26.50 | 866.20 | – |
| Gross margin | – | – | – | – | – | 86.9% | 87.2% | – |
Notice of Annual General Meeting to be held on September 29, 2026
The financial results for the period ended Jun 30, 2026.